News uniQure craters on Huntington’s gene therapy data uniQure has presented new results from its phase 1/2 study of its gene therapy for Huntington’s disease that
News BMS upgrades Evotec neurology alliance, now worth up to $4bn Bristol-Myers Squibb has expanded a long-running alliance with Evotec once again, paying another $50 million upfront to deepen their collaboration on drugs to treat neurod
Events Partner Content Protein Misfolding Drug Discovery Summit Discover & Translate Disease-Modifying Therapeutics
News UK backs start-up Potential Sciences' AI-powered drug hunt UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
